Profile | GDS4284 / 205173_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 4996.01 | 93 |
GSM687648 | Patient 402 control | 4372.3 | 92 |
GSM687653 | Patient 403 control | 4493.74 | 92 |
GSM687658 | Patient 404 control | 3581.21 | 90 |
GSM687663 | Patient 411 control | 3260 | 90 |
GSM687668 | Patient 422 control | 3735.85 | 91 |
GSM687673 | Patient 424 control | 3616.38 | 91 |
GSM687678 | Patient 425 control | 4733.52 | 93 |
GSM687683 | Patient 427 control | 3584.04 | 91 |
GSM687688 | Patient 428 control | 4126.77 | 92 |
GSM687695 | Patient 441 control | 6300.01 | 95 |
GSM687699 | Patient 443 control | 4580.15 | 93 |
GSM687704 | Patient 444 control | 2584.03 | 87 |
GSM687707 | Patient 448 control | 2990.4 | 89 |
GSM687712 | Patient 449 control | 4959.86 | 93 |
GSM687719 | Patient 450 control | 4619.08 | 93 |
GSM687724 | Patient 451 control | 4099.55 | 92 |
GSM687728 | Patient 452 control | 8167.36 | 96 |
GSM687646 | Patient 401 treated 24h | 4441.18 | 92 |
GSM687649 | Patient 402 treated 24h | 4887.63 | 93 |
GSM687665 | Patient 411 treated 24h | 3563.5 | 91 |
GSM687651 | Patient 402 treated 4 weeks | 3837.77 | 91 |
GSM687667 | Patient 411 treated 4 weeks | 4017.62 | 92 |
GSM687670 | Patient 422 treated 24h | 4070.75 | 92 |
GSM687671 | Patient 422 treated 4 weeks | 3972.34 | 91 |
GSM687654 | Patient 403 treated 24h | 3605.35 | 90 |
GSM687675 | Patient 424 treated 24h | 4050.73 | 92 |
GSM687685 | Patient 427 treated 24h | 3184.22 | 89 |
GSM687656 | Patient 403 treated 4 weeks | 4258.85 | 92 |
GSM687677 | Patient 424 treated 4 weeks | 2417.16 | 86 |
GSM687687 | Patient 427 treated 4 weeks | 3617.84 | 90 |
GSM687692 | Patient 428 treated 4h | 5178.4 | 94 |
GSM687716 | Patient 449 treated 4h | 4266.52 | 92 |
GSM687722 | Patient 450 treated 4h | 4278.28 | 92 |
GSM687680 | Patient 425 treated 24h | 5878.78 | 94 |
GSM687690 | Patient 428 treated 24h | 5917.7 | 94 |
GSM687700 | Patient 443 treated 24h | 5380.13 | 94 |
GSM687705 | Patient 444 treated 24h | 3831.97 | 91 |
GSM687714 | Patient 449 treated 24h | 5737.34 | 94 |
GSM687721 | Patient 450 treated 24h | 5789.65 | 94 |
GSM687682 | Patient 425 treated 4 weeks | 3748.78 | 91 |
GSM687694 | Patient 428 treated 4 weeks | 4863.23 | 93 |
GSM687702 | Patient 443 treated 4 weeks | 3793.52 | 91 |
GSM687718 | Patient 449 treated 4 weeks | 3607.1 | 91 |
GSM687723 | Patient 450 treated 4 weeks | 4327.57 | 92 |
GSM687661 | Patient 404 treated 4h | 4531.89 | 93 |
GSM687710 | Patient 448 treated 4h | 2874.35 | 88 |
GSM687726 | Patient 451 treated 4h | 4118.38 | 92 |
GSM687730 | Patient 452 treated 4h | 1660.21 | 83 |
GSM687660 | Patient 404 treated 24h | 16837.2 | 98 |
GSM687697 | Patient 441 treated 24h | 5777.48 | 94 |
GSM687709 | Patient 448 treated 24h | 3853.37 | 91 |
GSM687725 | Patient 451 treated 24h | 4297.58 | 92 |
GSM687729 | Patient 452 treated 24h | 15311 | 98 |
GSM687727 | Patient 451 treated 4 weeks | 2919.45 | 89 |
GSM687731 | Patient 452 treated 4 weeks | 5093.44 | 94 |